Navigation Links
Vivo Ventures Announces Promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner
Date:5/25/2011

PALO ALTO, Calif., May 25, 2011 /PRNewswire/ -- Vivo Ventures, LLC (“Vivo”) announced today the promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner in recognition of their contributions to the firm.

Dr. Yu first joined Vivo in 2004 and has been a Partner since 2007.   He currently serves as a Director of Sagent Pharmaceuticals, Nora Therapeutics and Synaptic International, and has been actively involved in many of the firm’s earlier private and public investments, including China KangHui Holdings, Achillion, Transcept, Tranzyme and Cubist.  In addition, he has had an operational role in a part-time capacity as Chief Business Officer of China KangHui Holdings overseeing their corporate development and investor relations efforts.  Prior to his time at Vivo, Dr. Yu was an early employee at aQuantive, which listed on Nasdaq in 2000 and ultimately was acquired for $6.5B by Microsoft.  Dr. Yu also currently serves on the Board of Governors for the Stanford Medical School Alumni Association.  Dr. Yu received his B.A. from Harvard University; his M.D. and MBA degrees are both from Stanford.

Dr. Zhao first began working with the firm in late 2005.  With his promotion to Managing Partner, he will now be heading Vivo’s China team.  He has made significant contributions to the firm’s success in China, including opening its Shanghai and Chengdu offices.  He was also instrumental in assisting in the formation of Vivo’s RMB denominated fund in partnership with the Chengdu Hi Tech Yinke Fund.  Dr. Zhao is actively involved in all of Vivo’s investments in China and will serve as the lead Vivo representative for Shanghai Hile, Sundise, and IMH.  Prior to joining Vivo, Dr. Zhao was a consultant with the Monitor Group focusing on life sciences.  Prior to that, he worked as a sales supervisor for Bristol Myers Squibb in Chengdu.  Dr. Zhao received his medical degree from West China University of Medical Sciences in Chengdu, his M.S. in Molecular Biology from Vrije University in Brussels, and his M.B.A. from Washington University, St. Louis.

"We are pleased to recognize the contributions of our new Managing Partners as we continue to strengthen and grow our team in the U.S. and in China,” said Frank Kung, Vivo Ventures co-founder and Senior Managing Partner.

About Vivo Ventures

Vivo Ventures is a life-sciences focused venture capital firm formed in 1996 with over $750M under management. With over 90 years of scientific and operational expertise in biotechnology, Vivo makes investment decisions for the Funds and helps its portfolio companies develop corporate strategy, arrange licensing agreements and strategic alliances, recruit key management personnel, and acquire new products and technology to accelerate growth. Its current portfolio includes more than 60 private and public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals, and medical devices. For more information, please visit www.vivoventures.com.


'/>"/>
SOURCE Vivo Ventures, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System
2. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
3. JumpStart Ventures Invests in Cleveland-based SPR Therapeutics
4. MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer
5. JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics
6. Leader Ventures Supports Innovative Drug Discovery Company Carmot
7. PharmaVentures Appoints Paul Phull as Senior Director
8. SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
9. JumpStart Ventures Invests In and Provides Entrepreneurial Assistance to Drug Development Company
10. Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures
11. BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):